article thumbnail

California’s low-cost insulin plans receive $100m manufacturing boost

Pharmaceutical Technology

Insulin prices made the headlines again as California governor Gavin Newsom announced plans on 7 July for the state to manufacture low-cost insulin. The state plans to work directly with a contract manufacturing organization (CMO) to manufacture low-cost insulin. In-house manufacturing the norm.

Insulin 328
article thumbnail

Why the drug pricing debate is focused on insulin

pharmaphorum

The treatment has been around for over a century but insulin has still become the centre of the ongoing discussion over pricing of pharmaceutical products. Ben Hargreaves looks at why insulin’s price is so controversial and whether this could be set to change. Insulin rationing. In the US, approximately 37.3

Insulin 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Elon Musk, pharma, and the future of Twitter

pharmaphorum

Musk’s arrival at the social platform has raised questions for users, which includes pharma companies who use Twitter for marketing and patients who utilise it to engage with their medical communities. We never know when there will be a concerted effort to attack a brand online. More than advertising.

article thumbnail

Pharma TV Ad Spending Trends: Companies in the Top Ten this Week

XTalks

In light of this, pharma wasted no time throwing some added cash towards TV ads. Taking advantage of the opportunity, the top ten pharma brands spent 17 percent more on TV ads in April 2020 compared to just a month prior, raising their monthly ad expenditures from $156 million to $183 million. million and $18.6 3. Dupixent.

Insulin 104
article thumbnail

Novo Nordisk: Prevention, digital tools and collaboration to define the future of diabetes

pharmaphorum

In our latest UK Leaders article Pinder Sahota, UK general manager at Novo Nordisk, tells us how he hopes to bring the NHS and pharma together to improve outcomes in diabetes and other long-term conditions. This will also mean the industry needs to think about how HCPs will want to interact with pharma companies. “If

article thumbnail

Top 7 Pharma Industry Leaders in 2020 By the Numbers

Delveinsight

Pharmaceutical companies may deal in both generic and brand-name drugs as well as medical devices. LANTUS (Insulin glargine) injection used to treat type 1 and 2 diabetes mellitus is another Sanofi product that is not far behind Dupixent. The global healthcare spending in 2020 was USD 8.3 trillion in 2021. billion) in 2020.

article thumbnail

Pharma Marketing Network - Untitled Article

Pharma Marketing Network

Robin also coaches people who want to become thought leaders to drive their marketing, personal branding and career advancements. Robin welcome to the Pharma marketing podcast and thanks for joining us today. Don ( PMN): Most pervasive diseases around the world not have to stick a needle to get insulin and just inhale it.

Insulin 52